Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Responsive Material Could be ‘Golden Ticket’ of Sensing

By Drug Discovery Trends Editor | January 7, 2015

A lipid membrane functionalised with DNA-linkers. Source: Lorenzo Di Michele/University of Cambridge

Researchers from the University of Cambridge have developed a new self-assembled material, which, by changing its shape, can amplify small variations in temperature and concentration of biomolecules, making them easier to detect. The material, which consists of synthetic spheres ‘glued’ together with short strands of DNA, could be used to underpin a new class of biosensors, or form the basis for new drug delivery systems.

The interplay between the lipid spheres, called giant vesicles, and the strands of DNA produces a unique response when the material is exposed to changes in temperature. Instead of expanding when heated – as is normally the case – the material contracts, a phenomenon known as negative thermal expansion. Details are published in the journal Nature Communications.

In addition to its role as a carrier of genetic information, DNA is also useful for building advanced materials. Short strands of DNA, dubbed ‘sticky ends’, can be customised so that they will only bind to specific complementary sequences. This flexibility allows researchers to use DNA to drive the self-assembly of materials into specific shapes.

Basing self-assembled materials around vesicles – synthetic versions of the soft sacs which envelop living cells – allows for even more flexibility, since the vesicles are so easily deformable. Using short DNA tethers with a cholesterol ‘anchor’ at one end and an exposed sticky DNA sequence at the other, the vesicles can be stuck together. When assembled into a hybrid DNA-lipid network, the DNA tethers can diffuse and rearrange, resulting in massive vesicle shape changes.

Besides negative thermal expansion, the researchers also found that changes in temperature lead to a significant variation in the porosity of the material, which is therefore highly controllable. A similar response is expected by changing the concentration of the DNA tethers, which could also be replaced by other types of ligand-receptor pairs, such as antibodies.

“The characteristics of this material make it suitable for several different applications, ranging from filtration, to the encapsulation and triggered release of drugs, to biosensors,” said Dr Lorenzo Di Michele of the University’s Cavendish Laboratory, who led the research. “Having this kind of control over a material is like a ‘golden ticket’ of sensing.”

Source: University of Cambridge


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50